Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

17.71
Delayed Data
As of Apr 19
 -0.21 / -1.17%
Today’s Change
10.85
Today|||52-Week Range
33.82
-6.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
AssetsCash897.8M598.5M679.2M963.0M
 
 
 
 
 
Short Term Investment Cash-90.8M-311.6M87.6M289.6M
 
 
 
 
 
Cash & Short Term Investments909.7M615.4M704.2M994.0M
 
 
 
 
 
 
ReceivablesReceivables7.2B7.3B7.4B7.1B
 
 
 
 
 
 
InventoriesInventories5.0B5.1B5.1B4.9B
 
 
 
 
 
 
Current AssetsPrepaid Expenses957.6M870.2M1.2B1.1B
 
 
 
 
 
Other Current Assets698.3M655.4M1.8B1.2B
 
 
 
 
 
Current Assets14.8B14.6B16.2B15.4B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross12.1B12.2B12.4B12.2B
 
 
 
 
 
Depreciation-4.0B-4.2B-4.4B-4.5B
 
 
 
 
 
Intangible Assets66.0B61.6B60.2B46.1B
 
 
 
 
 
Other Assets67.3B62.8B61.2B46.9B
 
 
 
 
 
Total Assets91.0B86.3B86.0B70.6B
 
 
 
 
 
 
LiabilitiesAccounts Payable2.4B2.3B2.4B2.1B
 
 
 
 
 
Short Term Debt1.9B1.2B2.7B3.6B
 
 
 
 
 
Accrued Expenses2.5B2.8B2.6B3.0B
 
 
 
 
 
Other Current Liabilities10.9B11.2B11.1B11.7B
 
 
 
 
 
Other Liabilities15.9B15.4B16.9B17.9B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt32.6B33.8B31.9B28.8B
 
 
 
 
 
Deferred Taxes-4.5B-4.7B-4.4B-2.7B
 
 
 
 
 
Other Liabilities1.6B2.0B2.0B1.8B
 
 
 
 
 
Total Liabilities55.4B56.7B55.7B51.9B
 
 
 
 
 
 
EquityMinority Interest-4.1M---15.5M-200.5M
 
 
 
 
Preferred Stock3.6B3.6B3.6B3.6B
 
 
 
 
 
Common Equity30.3B24.4B25.0B13.7B
 
 
 
 
 
Total Shareholder Equity33.9B28.0B28.6B17.4B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding1.0B1.0B1.0B1.0B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.